跳至主要内容
临床试验/IRCT20220901055848N1
IRCT20220901055848N1招募中3 期

Comparison of the effectiveness of duloxetine and nortriptyline in the treatment of pain in rheumatoid arthritis patients

Shahid Beheshti University of Medical Sciences0 个研究点目标入组 54 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
54

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 70 years(—)
性别
All

入选标准

  • Confirmation of the clinical diagnosis of mild to moderate Rheumatoid Arthritis by a rheumatologist
  • Presence of RF or AntiCCP in the serum of patients
  • Patients under treatment with methotrexate, prednisolone and hydroxychloroquine
  • Articular involvement without extra-articular involvement
  • Age range from 18 to 70 years
  • Pain complaint
  • Consent to participate in the study

排除标准

  • The presence of major psychiatric disorders, including depression, anxiety disorders, bipolar, schizophrenia, abuse of any substance and medication.
  • History of allergy to Duloxetine or Nortriptyline
  • Pregnancy, breastfeeding, or planning to become pregnant in the near future
  • Refusing to consent to receive treatment according to the instructions of this protocol

研究者

相似试验